A longitudinal brain-imaging study led by researchers at the University of Oslo's Center for Lifespan Changes in Brain and Cognition has found that measurable changes in cortical thickness are detectable at least seven years before amyloid-beta reaches the levels on PET scans currently used to diagnose Alzheimer's-related brain pathology. The study, by James M. Roe and colleagues, was published online August 19, 2026 in Nature Neuroscience.

The researchers combined 4,570 longitudinal MRI scans and 1,684 amyloid PET scans drawn from three cognitively healthy adult cohorts: the Center for Lifespan Changes in Brain and Cognition (LCBC) in Norway, the Berkeley Aging Cohort Study (BACS) in the United States, and normal-control participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Using MRI scans taken years before each person's amyloid PET scan turned positive, the team found that people who later crossed the amyloid threshold had a relatively thicker cortex and less cortical thinning than those who did not, a pattern detectable up to seven years ahead of conversion. Under current diagnostic frameworks, elevated amyloid on PET is treated as the earliest imaging sign of Alzheimer's disease, with structural brain changes assumed to follow later; this finding reorders that sequence.

James Michael Roe, the study's lead author and a postdoctoral researcher at LCBC at the time of the work, said the team found that "structural changes in the brain occur many years before high levels of plaque are seen" on the PET scans now used to flag early Alzheimer's disease. The authors report that many of the cortical thickness effects persisted even after accounting for each person's measured amyloid levels, suggesting some of the changes may be partly independent of amyloid accumulation itself, and that the regions and timing of thickness change loosely tracked the pattern and progression of amyloid deposition.